Olfen Patch (Diclofenac Sodium)

Diclofenac sodium blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in the skin, reducing the production of prostaglandins that cause pain, swelling, and fever. By acting directly at the site of application, the patch provides targeted anti‑inflammatory and analgesic effects.

The specific dose and wear time of Olfen Patch are determined by the prescribing healthcare professional based on the patient’s condition, age, and treatment response. Patients should follow the prescriber’s instructions and not exceed the recommended duration of use.

Safety data for topical diclofenac during pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against possible risks before prescribing. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative options with their clinician.

To request Olfen Patch, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Olfen Patch delivers diclofenac directly to the skin, offering localized pain relief with lower systemic exposure compared with oral tablets. This can reduce the risk of gastrointestinal and cardiovascular side effects common to oral NSAIDs, but skin irritation may be more frequent with the patch.

Olfen Patch should be stored at room temperature, below 25 °C, in its original packaging. Keep the patches away from moisture, excessive heat, and direct sunlight to maintain their adhesive properties and drug stability.

The patch is applied to clean, dry, and intact skin on the affected area. Remove the protective liner, press the patch firmly for several seconds, and ensure full contact. Follow the prescriber’s guidance on how long the patch should remain in place and when to replace it.

Serious risks include severe allergic skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, systemic NSAID toxicity (e.g., gastrointestinal bleeding, renal impairment, cardiovascular events), and rare cases of photosensitivity. Immediate medical attention is required if these symptoms develop.

Olfen Patch should be avoided in individuals with known hypersensitivity to diclofenac or any component of the patch, those with broken or infected skin at the application site, and patients with a history of severe NSAID‑related adverse events such as gastrointestinal ulcers or cardiovascular disease unless specifically advised by a physician.